Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Labeled version of Venetoclax (ABT 199), which is a potent and selective BCL-2 inhibitor that achieves potent antitumour activity while sparing platelets. It’s practical application is to treat chronic lymphocytic leukaemic cells and estrogen receptor-positive breast cancer.
您的位置：
